
Balancing Benefits and Blood Sugar: A Team Approach to PI3K Pathway Inhibitors in HR+/HER2- Metastatic Breast Cancer
Thursday, November 20, 2025
12:00 p.m. – 1:00 p.m. ET
Please note this TeleECHO program is 12:00 p.m. Eastern, 11:00 a.m. Central, 10:00 a.m. Mountain and 9:00 a.m. Pacific.